FindTrial
Sign In

Value of contrast-enhanced harmonic endoscopic ultrasound in upper gastrointestinal submucosal tumors

Value of contrast-enhanced harmonic endoscopic ultrasound in upper gastrointestinal submucosal tumors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047463
Enrollment
Unknown
Registered
2021-06-19
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

submucosal tumor

Interventions

Gold Standard:pathology and immunohistochemistry
Index test:contrast-enhanced&#32
harmonic&#32
endoscopic&#32
ultrasound

Sponsors

The second hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients with submucosal tumors of upper digestive tract; 2.Complete postoperative histopathological and immunohistochemical data were obtained.

Exclusion criteria

Exclusion criteria: 1.Allergic to contrast agent SonoVue; 2.Patients with contraindications, such as severe heart failure and severe chronic obstructive pulmonary disease; 3.Age less than 18; 4.Pregnancy; 5.Complicated with other malignant tumors, or treated with chemotherapy or radiotherapy.

Design outcomes

Primary

MeasureTime frame
Accuracy;sensitivity;specificity;—

Countries

China

Contacts

Public ContactZhou Yubao

The second hospital of Anhui Medical University

15856959213@163.com+86 15856959213

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026